The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
High mobility group protein-1 (HMG-1) is a unique activator of p53
Open accessAbstract
The binding of p53 protein to DNA is stimulated by its interaction with covalent as well as noncovalent modifiers. We report the identification of a factor from HeLa nuclear extracts that activates p53 DNA binding. This factor was purified to homogeneity and identified as the high mobility group protein, HMG-1. HMG-1 belongs to a family of highly conserved chromatin-associated nucleoproteins that bend DNA and facilitate the binding of various transcription factors to their cognate DNA sequences. We demonstrate that recombinant His-tagged HMG-1 enhances p53 DNA binding in vitro and also that HMG-1 and p53 can interact directly in vitro. Unexpectedly, HMG-1 also stimulates DNA binding by p53Delta30, a carboxy-terminally deleted form of the protein that is considered to be constitutively active, suggesting that HMG-1 stimulates p53 by a mechanism that is distinct from other known activators of p53. Finally, using transient transfection assays we show that HMG-1 can increase p53 and p53Delta30-mediated transactivation in vivo. HMG-1 promotes the assembly of higher order p53 nucleoprotein structures, and these data, along with the fact that HMG-1 is capable of bending DNA, suggest that HMG-1 may activate p53 DNA binding by a novel mechanism involving a structural change in the target DNA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047 · cited 6×
“1993), GADD45 (Kastan et al. 1992), cyclin G (Okamoto and Beach 1994; Zauberman et al.”
BackgroundInfluentialCrystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,551 · cited 2×
“The region in p53 that contributes to sequence-specific DNA binding spans the central portion of the protein, extending approximately from amino acid 100 to 300 (Cho et al. 1994 and references therein).”
BackgroundKo, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344
Self-citationDNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100
Self-citationDefinition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Vogelstein, B. (1992) · Cell · doi:10.1016/0092-8674(92)90421-8 · Cited by 1,862
The p53-mdm-2 autoregulatory feedback loop.
Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801
mdm2 expression is induced by wild type p53 activity.
Barak, Y., Juven, T., Haffner, R., & Oren, M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05678.x · Cited by 1,290
[36] Eukaryotic gene transcription with purified components
Dignam, J. D., Martin, P. L., Shastry, B. S., & Roeder, R. G. (1983) · Methods in Enzymology · doi:10.1016/0076-6879(83)01039-3 · Cited by 963
Regulation of the specific DNA binding function of p53
Hupp, T. R., Meek, D. W., Midgley, C. A., & Lane, D. P. (1992) · Cell · doi:10.1016/0092-8674(92)90562-q · Cited by 909
Induction of the growth inhibitor IGF-binding protein 3 by p53
Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B. R., & Kley, N. (1995) · Nature · doi:10.1038/377646a0 · Cited by 869
HMG domain proteins: architectural elements in the assembly of nucleoprotein structures
Grosschedl, R., Giese, K., & Pagel, J. (1994) · Trends in Genetics · doi:10.1016/0168-9525(94)90232-1 · Cited by 813
Bustin, M., & Reeves, R. (1996) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(08)60360-8 · Cited by 763
Self-citationMapping of the p53 and mdm-2 interaction domains.
Chen, J., Marechal, V, & Levine, A. J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.4107 · Cited by 689
Specific Recognition of Cruciform DNA by Nuclear Protein HMG1
Bianchi, M. E., Beltrame, M., & Paonessa, G. (1989) · Science · doi:10.1126/science.2922595 · Cited by 601
Specific Binding of Chromosomal Protein HMG1 to DNA Damaged by the Anticancer Drug Cisplatin
Pil, P. M., & Lippard, S. J. (1992) · Science · doi:10.1126/science.1566071 · Cited by 496
p53 in growth control and neoplasia
Gottlieb, T. M., & Oren, M. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(95)00019-c · Cited by 481
Identification of redox/repair protein Ref-1 as a potent activator of p53.
Jayaraman, L., Murthy, K. G., Zhu, C., Curran, T., Xanthoudakis, S., & Prives, C. (1997) · Genes & Development · doi:10.1101/gad.11.5.558 · Cited by 481
Self-citationCyclin G is a transcriptional target of the p53 tumor suppressor protein.
Okamoto, K., & Beach, D. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06807.x · Cited by 455
Small peptides activate the latent sequence-specific DNA binding function of p53
Hupp, T. R., Sparks, A., & Lane, D. P. (1995) · Cell · doi:10.1016/0092-8674(95)90165-5 · Cited by 434
Lee, S., Elenbaas, B., Levine, A., & Griffith, J. (1995) · Cell · doi:10.1016/s0092-8674(05)80006-6 · Cited by 405
Jayaraman, L., & Prives, C. (1995) · Cell · doi:10.1016/s0092-8674(05)80007-8 · Cited by 345
Self-citationPaull, T. T., Haykinson, M. J., & Johnson, R. C. (1993) · Genes & Development · doi:10.1101/gad.7.8.1521 · Cited by 323
Agrawal, A., & Schatz, D. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80181-6 · Cited by 303
Allosteric activation of latent p53 tetramers
Hupp, T. R., & Lane, D. P. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00195-0 · Cited by 301
A Mutant p53 That Discriminates between p53-Responsive Genes Cannot Induce Apoptosis
Friedlander, P., Haupt, Y., Prives, C., & Oren, M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4961 · Cited by 278
Self-citationDNA-binding properties of the HMG domain of the lymphoid-specific transcriptional regulator LEF-1.
Giese, K., Amsterdam, A., & Grosschedl, R. (1991) · Genes & Development · doi:10.1101/gad.5.12b.2567 · Cited by 265
Stimulation of V(D)J cleavage by high mobility group proteins
van Gent, D. C. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2665 · Cited by 259
A signature for the HMG‐1 box DNA‐binding proteins
Landsman, D., & Bustin, M. (1993) · BioEssays · doi:10.1002/bies.950150807 · Cited by 251
Self-citationHMG1 interacts with HOX proteins and enhances their DNA binding and transcriptional activation.
Zappavigna, V., Falciola, L., Helmer-Citterich, M., Mavilio, F., & Bianchi, M. E. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00878.x · Cited by 234
Zwilling, S., König, H., & Wirth, T. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07103.x · Cited by 226
Short-Range DNA Looping by the Xenopus HMG-Box Transcription Factor, xUBF
Bazett-Jones, D. P., Leblanc, B., Herfort, M., & Moss, T. (1994) · Science · doi:10.1126/science.8178172 · Cited by 218
The DNA-bending protein HMG-1 enhances progesterone receptor binding to its target DNA sequences.
Oñate, S. A., Prendergast, P., Wagner, J. P., Nissen, M., Reeves, R., Pettijohn, D. E., & Edwards, D. P. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.5.3376 · Cited by 209
The HMG-1 box protein family: classification and functional relationships
Baxevanis, A. D., & Landsman, D. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.9.1604 · Cited by 208
Shaw, P., Freeman, J., Bovey, R., & Iggo, R. D. (1996) · PubMed · Cited by 202
Wild-type p53 adopts a ‘mutant’-like conformation when bound to DNA.
Halazonetis, T. D., Davis, L. J., & Kandil, A. N. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05743.x · Cited by 193
High-mobility-group 1 protein mediates DNA bending as determined by ring closures.
Pil, P. M., Chow, C. S., & Lippard, S. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9465 · Cited by 189
Ge, H., & Roeder, R. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32531-0 · Cited by 174
Interaction of p53 with Its Consensus DNA-Binding Site
Wang, Y., Schwedes, J. F., Parks, D., Mann, K., & Tegtmeyer, P. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.4.2157 · Cited by 155
Zauberman, A., Lupo, A., & Oren, M. (1995) · PubMed · Cited by 145
Sawchuk, D. J., Weis‐Garcia, F., Malik, S., Besmer, E., Bustin, M., Nussenzweig, M. C., & Cortés, P. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.11.2025 · Cited by 137
Self-citationFour p53 DNA-binding domain peptides bind natural p53-response elements and bend the DNA.
Balagurumoorthy, P., Sakamoto, H., Lewis, M. S., Zambrano, N., Clore, G. M., Gronenborn, A. M., Appella, E., & Harrington, R. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8591 · Cited by 129
High mobility group proteins 1 and 2 function as general class II transcription factors
Singh, J., & Dixon, G. H. (1990) · Biochemistry · doi:10.1021/bi00478a026 · Cited by 126
High mobility group proteins 1 and 2 stimulate transcription in vitro by RNA polymerases II and III.
Tremethick, D. J., & Molloy, P. L. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)62712-2 · Cited by 123
Nagaich, A. K., Appella, E., & Harrington, R. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.23.14842 · Cited by 91
Verrier, C. S., Roodi, N., Yee, C. J., Bailey, L., Jensen, R. A., Bustin, M., & Parl, F. F. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.8.9962 · Cited by 74
Self-citationOgawa, Y., Aizawa, S., Shirakawa, H., & Yoshida, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.16.9272 · Cited by 72
Nagaich, A. K., Zhurkin, V. B., Sakamoto, H., Gorin, A. A., Clore, G. M., Gronenborn, A. M., Appella, E., & Harrington, R. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.23.14830 · Cited by 66
Serological analysis of species specificity in the high mobility group chromosomal proteins.
Romani, M., Rodman, T. C., Vidali, G., & Bustin, M. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30161-8 · Cited by 55
Self-citation[11] Preparation and application of immunological probes for nucleosomes
Bustin, M. (1989) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(89)70049-5 · Cited by 35
Self-citationFunctional dissection of p53 tumor suppressor protein
Jayaraman, L., Freulich, E., & Prives, C. L. (1997) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(97)83020-0 · Cited by 27
Self-citation
Cited by
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Cisplatin: mode of cytotoxic action and molecular basis of resistance
Siddik, Z. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206933 · Cited by 3,335
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
Jamieson, E. R., & Lippard, S. J. (1999) · Chemical Reviews · doi:10.1021/cr980421n · Cited by 2,949
The complexity of p53 modulation: emerging patterns from divergent signals
Giaccia, A. J., & Kastan, M. B. (1998) · Genes & Development · doi:10.1101/gad.12.19.2973 · Cited by 1,314
p53 and Human Cancer: The First Ten Thousand Mutations
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60785-x · Cited by 986
Metadata
- Authors
- Jayaraman, L., Moorthy, N. C., Murthy, K. G. K., Manley, J. L., Bustin, M., & Prives, C.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1998-02-15
- Volume
- 12
- Issue
- 4
- Pages
- 462-472
- ISSN
- 0890-9369 (ISSN-L)
- OpenAlex
- W2155740016
- Cited by
- 321
- References
- 54
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.